PP2, a selective Src-kinase family inhibitor that blocks integrin-induced FAK phosphorylation (Xia et al., 2004), abolished the phosphorylation of tyrosine 397 of FAK and serine 473 of Akt with both B/03 and MPC/04 infection (Figures 5B,C). Here, AKT1 is linked to infection.